Hepatitis D: eMedicine Gastroenterology

Links shared publicly online about this topic.

  • 1,123
    total visits

Hepatitis D: eMedicine Gastroenterology

emedicine.medscape.com

Overview: Hepatitis D virus (HDV) is an RNA virus that is structurally unrelated to hepatitis A, B, or C virus. It was discovered in 1977. HDV causes a unique infection that requires the assistance of viral particles ...

View full resource at emedicine.medscape.com

Tags: Gastroenterology, Liver Condition, Hepatitis, Hepatitis A, Hepatitis D, Infection

  • Share

Most Recently Shared on June 2, 2010 at 7:42 pm By:

J_Bohlen Julie Bohlen

Hepatitis D virus (HDV) is an RNA virus that is structurally unrelated to hepatitis A, B, or C virus. More on Hep. D. http://bit.ly/cObrML

2 years ago...

Gastroenterology News - Meta-analysis: antiviral treatment for hepatitis D |3967144

mdlinx.com — “Gastroenterology Medical Article: Meta-analysis: antiviral treatment for hepatitis DView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 12:42 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Meta-analysis: antiviral treatment for hepatitis D: Alimentary Pharmacology and Therapeutics http://t.co/7YHASQYz #GI

2 months ago...

Gastroenterology Article | Hepatic Encephalopathy

mdlinx.com — “Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy- a double-blind placebo-controlled studyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 19, 2011 at 1:24 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepa... http://t.co/d4taZ2m #GI

9 months ago...

Gastroenterology Article | Hepatitis C, Chronic

mdlinx.com — “Efficacy and safety of peginterferon α-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin: an open-label study in central and Eastern EuropeView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 10, 2011 at 2:36 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Efficacy and safety of peginterferon α-2a (40 kD) plus ribavirin among patients with chronic hepatitis... http://bit.ly/kkfJhe #GI

1 year ago...

Gastroenterology Article | Hepatitis B

mdlinx.com — “Trends in mortality after diagnosis of hepatitis B or C infection: 1992--2006View full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 27, 2011 at 10:40 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Trends in mortality after diagnosis of hepatitis B or C infection: 1992–2006: Journal of Hepatology http://bit.ly/dYFS9v #GI

1 year ago...

Gastroenterology Article | Hepatitis C, Chronic

mdlinx.com — “Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 21, 2011 at 1:10 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and po... http://bit.ly/g7Alxm #GI

1 year ago...

Predictors of Response in Hepatitis C Virus Disease Therapy | Gastroenterology

touchgastroenterology.com — “Hepatitis C virus, therapy, response, host genetic variation, genome-wide associationView full resource at touchgastroenterology.com

  • View Related
  • Share

Most Recently Shared on April 19, 2011 at 1:09 pm By:

touchGASTRO touchGASTRO Gastroenterology and Medical Journal

Predictors of Response in Hepatitis C Virus Disease Therapy http://bit.ly/dKYDZv

1 year ago...

Hepatitis B Immunisation in Low-risk Populations in Developing Countries | Gastroenterology

touchgastroenterology.com — “Hepatitis B Immunisation in Low-risk Populations in Developing CountriesView full resource at touchgastroenterology.com

  • View Related
  • Share

Most Recently Shared on December 31, 2010 at 12:57 pm By:

touchGASTRO touchGASTRO Gastroenterology and Medical Journal

Hepatitis B Immunisation in Low-risk Populations in Developing Countries http://bit.ly/hZXrE1

1 year ago...

NHS Evidence - Gastroenterology and liver diseases - Screening options for hepatitis C in Belgium

library.nhs.uk — “Bibliographic details Screening options for hepatitis C in Belgium. Brussels: Belgian Health Care Knowledge Centre (KCE). Study 2010-27. 0 StatusThis is a bibliographic record of an ongoing health technology assessment being undertaken by a member of INAHTA. Links to the published report and any other relevant documentation will be added when available. Indexing statusSubject indexing assigned by CRD Index termsBelgium; Hepatitis C; Humans; Mass ScreeningView full resource at library.nhs.uk

  • View Related
  • Share

Most Recently Shared on December 10, 2010 at 9:41 pm By:

Gastro_Digestiv OrganizedWisdom GI OW Health

Screening options for hepatitis C in Belgium: Bibliographic details Screening options for hepatitis C in Belgium... http://bit.ly/dP9xkt

1 year ago...

Gastroenterology Article | Hepatitis C

mdlinx.com — “Big Changes Are Coming in Hepatitis CView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 13, 2010 at 10:03 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Big Changes Are Coming in Hepatitis C: Current Gastroenterology Reports http://bit.ly/d8nNgm #GI

2 years ago...

Gastroenterology Article | Hepatitis C

mdlinx.com — “Pharmacokinetics and Pharmacodynamics of Peginterferon and Ribavirin: Implications for Clinical Efficacy in the Treatment of Chronic Hepatitis CView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 5, 2010 at 3:29 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Pharmacokinetics and Pharmacodynamics of Peginterferon and Ribavirin: Implications for Clinical Efficacy in ... http://bit.ly/cOt8dT #GI

2 years ago...

Gastroenterology Article | Hepatitis

mdlinx.com — “Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 3, 2010 at 2:51 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to convent... http://bit.ly/d4oPBm #GI

2 years ago...

Gastroenterology News & Articles - MDLinx - Hepatitis on #MDlinx

mdlinx.com — “Gastroenterology News & Articles - MDLinx - Hepatitis on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 25, 2010 at 6:04 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Autoimmune hepatitis triggered by nitrofurantoin: a case series: Journal of Medical Case Reports http://bit.ly/brL3dN #GI

2 years ago...

Gastroenterology News & Articles - MDLinx - Hepatitis C on #MDlinx

mdlinx.com — “Gastroenterology News & Articles - MDLinx - Hepatitis C on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 10, 2010 at 6:00 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Proteome-wide Anti–Hepatitis C Virus (HCV) and Anti-HIV Antibody Profiling for Predicting and Monitoring the Re... http://bit.ly/d93Vwn #GI

2 years ago...

Hepatitis C: eMedicine Pediatrics: General Medicine

emedicine.medscape.com — “Overview: Hepatitis C virus (HCV) is one of 6 viruses (along with hepatitis A, B, D, E, and G viruses) that cause viral hepatitis. Prior to identification of the virus, it was termed non-A/non-B hepatitis to distinguish ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on July 23, 2010 at 9:41 pm By:

NVHR releases statement on New York Times article 'Hope against Hepatitis C'

news-medical.net — “In response to today's New York Times article, "Hope against Hepatitis C," Andrew Muir, M.D., M.H.S., Director, Gastroenterology/Hepatology Research, Duke Clinical Research Institute and Steering Committee Member of the National Viral Hepatitis Roundtable (NVHR) released the following statement:View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 23, 2010 at 9:47 am By:

NewsMedical News-Medical.Net Health News

NVHR releases statement on New York Times article 'Hope against Hepatitis C': In response to today's New York Time... http://bit.ly/b4V9Or

2 years ago...

Advertisement